Researchers including one of Indian-origin have created a new molecule for prostate cancer that has shown great efficacy when tested in mice. The findings suggest that the new therapeutic might be a viable treatment for prostate cancer in humans too if it is found effective the future clinical trials. The treatment was designed to inhibit the activity of a protein called PAK-1 which contributes to the development of highly invasive prostate cancer cells. PAK-1 is kind of like an on/off switch said study co-author Somanath Shenoy associate professor at University of Georgia College of Pharmacy in the US. When it
